Cat. No. ARI0225
The 35.1 cell line is a hybridoma cell line producing the monoclonal antibody 35.1, which specifically targets human CD2, a surface molecule expressed on T cells and natural killer (NK) cells. This cell line was established by fusing spleen cells from an immunized animal with NS1/1 myeloma cells. The immunization was performed using human T lymphocytes that had been activated with phorbol myristic acid (PMA).
| Morphology | Lymphoblast-like |
| Growth Mode | Suspension |
| Temperature | 37°C |
| Atmosphere | 5% CO₂ |
| Sterility testing | Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination. |
| Mycoplasma testing | Negative for mycoplasma through PCR analysis |
Intended Use: This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer: Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use.
This product is provided "AS IS". For Research Use Only. Not for human or animal therapeutic use.